{"id":"https://openalex.org/A5041702452","orcid":"https://orcid.org/0000-0002-3093-9874","observed_orcids":["https://orcid.org/0000-0002-3093-9874"],"display_name":"Asako Ota","raw_author_names":["Asako Ota"],"full_name":"Asako Ota","works_count":5,"cited_by_count":8,"summary_stats":{"2yr_mean_citedness":0.0,"h_index":2,"i10_index":0},"ids":{"openalex":"https://openalex.org/A5041702452","orcid":"https://orcid.org/0000-0002-3093-9874","observed_orcids":["https://orcid.org/0000-0002-3093-9874"]},"affiliations":[{"institution":{"id":"https://openalex.org/I4210124581","ror":"https://ror.org/02w95ej18","display_name":"Suita Municipal Hospital","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210124581"]},"years":[2024,2023,2022]}],"last_known_institutions":[{"id":"https://openalex.org/I4210124581","ror":"https://ror.org/02w95ej18","display_name":"Suita Municipal Hospital","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210124581"]}],"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","count":2,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","count":2,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","count":2,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","count":1,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","count":1,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"topic_share":[{"id":"https://openalex.org/T12009","display_name":"Hedgehog Signaling Pathway Studies","value":3.2e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11730","display_name":"Autoimmune Bullous Skin Diseases","value":2.17e-05,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12937","display_name":"Chemotherapy-related skin toxicity","value":1.75e-05,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","value":1.02e-05,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12355","display_name":"Genetic and rare skin diseases.","value":8.7e-06,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"x_concepts":[{"id":"2780564577","wikidata":"https://www.wikidata.org/wiki/Q179945","display_name":"Psoriasis","score":0.9051001071929932},{"id":"71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","score":0.900351881980896},{"id":"142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","score":0.5718742609024048},{"id":"126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","score":0.27265238761901855},{"id":"121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","score":0.25615453720092773}],"counts_by_year":[{"year":2022,"works_count":2,"oa_works_count":1,"cited_by_count":3},{"year":2023,"works_count":2,"oa_works_count":2,"cited_by_count":0},{"year":2024,"works_count":1,"oa_works_count":1,"cited_by_count":4},{"year":2025,"works_count":0,"oa_works_count":0,"cited_by_count":1}],"display_name_alternatives":["Asako Ota"],"block_key":"a ota","works_api_url":"https://api.openalex.org/works?filter=author.id:A5041702452","awards_count":0,"updated_date":"2026-11-04T11:47:51","created_date":"2022-04-19T00:00:00"}